NCT05136053View on ClinicalTrials.gov

A Study Investigating Lu AG22515 in Healthy Adults

PHASE1CompletedINTERVENTIONAL
Enrollment

58

Participants

Timeline

Start Date

March 18, 2022

Primary Completion Date

August 5, 2023

Study Completion Date

August 5, 2023

Conditions
Healthy Participants
Interventions
DRUG

Lu AG22515

sterile solution for infusion

DRUG

Placebo

sterile solution for infusion

DRUG

Immune System Activator

sterile powder for injection

Trial Locations (2)

90806

CenExel CNS, Long Beach

07094

Frontage Clinical Research Inc, Secaucus

All Listed Sponsors
lead

H. Lundbeck A/S

INDUSTRY